Latest Articles
EndoDiagnosis Announces Links Medical Clinic as Western Canada's First Permanent TIER-1 ENDOSURE Testing Program for the Rapid Diagnosis of Endometriosis - Erie Times-News
EndoDiagnosis Announces Links Medical Clinic as Western Canada's First Permanent TIER-1 ENDOSURE Testing Program for the Rapid Diagnosis of Endometriosis Erie Times-News
Published: Dec. 22, 2025, 6:39 p.m.
EndoDiagnosis Announces Links Medical Clinic as Western Canada's First Permanent TIER-1 ENDOSURE Testing Program for the Rapid Diagnosis of Endometriosis - The News Journal
EndoDiagnosis Announces Links Medical Clinic as Western Canada's First Permanent TIER-1 ENDOSURE Testing Program for the Rapid Diagnosis of Endometriosis The News Journal
Published: Dec. 22, 2025, 5:37 p.m.
Get $15 off orders of $45+ from the TikTok Shop when you pay with Venmo - Mashable
Get $15 off orders of $45+ from the TikTok Shop when you pay with Venmo Mashable
Published: Dec. 22, 2025, 2:35 p.m.
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial - marketscreener.com
AstraZeneca Starts Phase 3 Post-Surgery Endometrial Cancer Trial marketscreener.com
Published: Dec. 22, 2025, 11:40 a.m.
ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer - Nasdaq
ENHERTU Gets Tenth Breakthrough Therapy Designation, Launches Phase 3 Trial In Endometrial Cancer Nasdaq
Published: Dec. 22, 2025, 11:34 a.m.
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer - Nature
Improving the performance of polymerase chain reaction for microsatellite instability testing in endometrial cancer Nature
Published: Dec. 22, 2025, 10:55 a.m.
Hisense 55-inch Class QLED 4K CanvasTV Series for just $697.99 - Mashable
Hisense 55-inch Class QLED 4K CanvasTV Series for just $697.99 Mashable
Published: Dec. 22, 2025, 10 a.m.
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com - Investing.com South Africa
First patient dosed in phase 3 trial evaluating ENHERTU in endometrial cancer By Investing.com Investing.com South Africa
Published: Dec. 22, 2025, 8:15 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - The AI Journal
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer The AI Journal
Published: Dec. 22, 2025, 7:31 a.m.
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer - itemonline.com
DESTINY-Endometrial02 Phase 3 Trial of ENHERTU® Initiated as Adjuvant Therapy in Patients with HER2 Expressing Endometrial Cancer itemonline.com
Published: Dec. 22, 2025, 7:30 a.m.
Link copied to clipboard!